| NCT ID | NCT07356518 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-22 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-22 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to compare the management of chronic hypertension during pregnancy using telehealth visits with blood pressure telemonitoring and health coaching as compared to standard in person clinic visits. The study involves pregnant woman aged 18-45 who are receiving care for chronic hypertension. Participation in this research study will last until their baby is delivered. The number of in-person clinic visits depends on the participant's treatment assignment. Those assigned to telehealth visits will have telehealth visits alternating with clinic visits every two weeks until the end of pregnancy week 31. Those assigned to telehealth visits will also have five sessions with a health coach via telephone or video from the time of enrollment until the end of pregnancy week 36.
Eligibility Criteria
Inclusion Criteria: * prior diagnosis of Chronic hypertension (cHTN) * Pregnant women * Known: documented diagnosis or on antihypertensive medication prior to pregnancy Exclusion Criteria: * Any significant chronic medical or psychiatric illness that, in the investigator's opinion, would prevent participation in the study * Cardiac disorders: cardiomyopathy, angina, Coronary Artery Disease (CAD) * Current substance abuse disorder * Multifetal pregnancy * Participation in another study without prior approval * Plan to deliver outside Atrium Health Wake Forest Baptist * Prior stroke * Severe hypertension * Suspected or known fetal major structural/chromosomal abnormality or fetal demise
Contact & Investigator
Aderonke O Adeniyi, MD, MS
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT07356518 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07356518 currently recruiting?
Yes, NCT07356518 is actively recruiting participants. Contact the research team at Ejiro.Obioma@Advocatehealth.org for enrollment information.
Where is the NCT07356518 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT07356518 clinical trial?
NCT07356518 is sponsored by Wake Forest University Health Sciences. The principal investigator is Aderonke O Adeniyi, MD, MS at Wake Forest University Health Sciences. The trial plans to enroll 60 participants.